Roche Products Pty Limited - Notification - N94050

Applicant(s)

  • Roche Products Pty Limited

Notification number(s)

  • N94050

Summary

Roche Products Pty Ltd proposes to supply NeoRecormon products to customers at their home address (the Home Delivery Service) on condition that the customer is referred to the Home Delivery Service by one of two specialists selected by Roche Products (which may increase to up to 18 specialists) and acquires the services of Sydney Drug Stores Pty Ltd (trading as Pharmacy Direct), or such other pharmacy that may change from time to time, for administration of the prescription and delivery details of the service. The services of the Australian Postal Corporation will be employed to deliver the products to the customers.

NeoRecormon (epoetin beta) is a prescription drug used to treat renal anaemia.

This notification was allowed to stand on 18 August 2009.

Notifications

Document title Date

ACCC correspondence

Document title Date